RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Aperio Clinical Outcomes, a leading clinical research organization (CRO), has relocated its headquarters to the American Tobacco Campus, a hub for innovation in downtown Durham, NC.
The American Tobacco Campus (ATC) sits at the heart of downtown Durham, which has become one of America’s most dynamic regions as it evolved from a once-thriving industrial center into a mecca for higher education, creativity, and medical and technological advancements. The legacy of the American Tobacco Factory, originally built in 1857, was restored over the last 20 years after being purchased by the Capitol Broadcasting Company in 2002. The revitalization of the campus has resulted in award-winning architecture and landscapes, with over a million people coming each year to the ATC for work and entertainment. It has become the home of some of the Research Triangle’s most progressive companies and now includes Aperio Clinical Outcomes.
“Aperio’s culture is based on innovation – we work with sponsors that have groundbreaking medical advancements in an industry that has continuous technological breakthroughs and is always finding new ways to evolve,” says Aperio Founder and CEO Faye Woolf. “It was essential that our new location be around like-minded organizations in an environment that shares our passion for innovation and developing medicines to improve patients' lives. The American Tobacco Campus was a clear fit, and we are so excited to be contributing to the pioneering advancements that have come from this innovative and eclectic campus.”
Says Adam Klein, Director of Strategy at Capitol Broadcasting Company, “We are honored for Aperio to be our newest tenants and are excited for their contributions to downtown Durham’s innovation. Throughout the Triangle region, there is no real estate option as unique as the American Tobacco Campus, with its blend of historic and modern as well as serene outdoor space. We know the ATC environment will contribute to the ongoing inspiration and innovation that Aperio is known for.”
About Aperio Clinical Outcomes
In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com